Project
Modulating Ire1 to prevent Parkinson' Disease
| Reference: | FCT-ANR/NEU-NMC/0006/2013 |
|---|---|
| Financing program: | 3599-PPCDT |
| Funding organization: | Fundação para a Ciência e a Tecnologia |
| Associated institutions: | Universidade de Lisboa |
Similar Items
Modulating Ire1 to prevent Parkinson' Disease
Pharmacological Modulators of Parkinsons Disease-Associated Proteins
INNOVATIVE WATER-SOLUBLE PHYTOMATERIAL INHIBITORs FOR ALZHEIMERs AND PARKINSONs DISEASES PREVENTION
S-Glutathionylation in Parkinson´s Disease.
Parkinson’s Disease and Mitochondrial dysfunction: the role of PINK1 in mitochondria maintenance and clearance
The transcriptional landscape of Parkinson´s disease
Exploring the biophysical link between Gaucher disease and Parkinson?s disease
Using Mainstream Devices to Monitor Parkinson´s Disease
DECIPHERING THE ROLE SIRT2 IN PARKINSON DISEASE
Underlying role of glycation in the pathogenesis of Parkinsons disease
Cognitive Disorders in Late-Stage Parkinson´s Disease
Cardiovascular risk factors associated with Parkinson´s disease
Modulation of Rac1 towards Neuroprotection in Stroke.
New drugs to target Neurodegenerattion and Neuroinflammation in Parkinson ´s Disease
Dissecting the role of alpha-synuclein phosphorylation in Parkinson’s disease
DECIPHERING THE ROLE OF ALFA-SYNUCLEIN PHOSPHORYLATION IN PARKINSON’S DISEASE
DECIPHERING THE ROLE OF ALFA-SYNUCLEIN PHOSPHORYLATION IN PARKINSON’S DISEASE
Heme/Irin-Driven microglia polarization in Parkinson`s disease
Targeting the glycation defenses as a protective strategy for Parkinson’s disease
Targeting the glycation defenses as a protective strategy for Parkinson’s disease
Slow and Rapid Progression Parkinson´s Disease: Molecular Determinants and Biomarkers
Substantia Nigra pars compacta in Parkinson´s Disease: Function and Vulnerability
SCREENING AND VALIDATION OF MOLECULES WITH THERAPEUTIC PROPERTIES IN IN VIVO MODELS OF PARKINSON’S DISEASE
Freezing of Gait after Deep Brain Stimulation in Parkinson´s Disease Patients
SCREENING AND VALIDATION OF MOLECULES WITH THERAPEUTIC PROPERTIES IN IN VIVO MODELS OF PARKINSON’S DISEASE
Unraveling the neuroprotective role of TUDCA in Parkinson´s disease: targeting oxidative stress and mitophagy
Molecular mechanisms modulating Prrxl1-mediated development of pain-processing neurons
Earth observation service for preventive control of insect disease vectors
Earth observation service for preventive control of insect disease vectors
Tailor-made foods for the prevention of Alzheimer disease and cognitive decline
Exploring the impact of gamma-delta T cell subsets in motor performance and Parkinson´s disease progression
THE INTERPLAY BETWEEN ALPHA-SYNUCLEIN AND AUTOPHAGY: TOWARDS THE UNDERSTANDING OF THE MOLECULAR BASIS OF THE PARKINSON’S DISEASE
New Edge in the therapeUtics of PaRkinsON´s diSeaSe from SeaweedS
Toward an understanding of protein glycation in Parkinson's disease: in vitro and in vivo studies of folding, aggregation and degradation pathways of alpha-synuclein, synphilin-1 and parkin under glycation conditions.
Modulation of carotid body activity as a therapeutic intervention in metabolic diseases.
A sophisticated multi-parametric system for the continuous-effective assessment and monitoring of motor status in parkinson’s disease and other neurodegenerative diseases
Care for Late Stage Parkinsonism
Prevention of periodontal disease in dogs: an experimental approach using an antimicrobial peptide
Deciphering the molecular mechanisms linking alpha-synuclein dysfunction and cytotoxicity in Parkinson's disease - the role of GDNF
Pb-NeuroPD: The role of lead exposure in the nervous system and Parkinson’s disease onset and progression
Related publications
Loading publications...